Accent Therapeutics secures $75M in Series C funding feast
TLDR: Accent Therapeutics Raises $75M in Series C Funding Accent Therapeutics, a biopharmaceutical company focused on small molecule precision cancer therapies, has raised $75 million in Series C funding. The round was